Human immune globulin treatment controls Zika viremia in pregnant rhesus macaques

PLoS One. 2022 Jul 14;17(7):e0266664. doi: 10.1371/journal.pone.0266664. eCollection 2022.

Abstract

There are currently no approved drugs to treat Zika virus (ZIKV) infection during pregnancy. Hyperimmune globulin products such as VARIZIG and WinRho are FDA-approved to treat conditions during pregnancy such as Varicella Zoster virus infection and Rh-incompatibility. We administered ZIKV-specific human immune globulin as a treatment in pregnant rhesus macaques one day after subcutaneous ZIKV infection. All animals controlled ZIKV viremia following the treatment and generated robust levels of anti-Zika virus antibodies in their blood. No adverse fetal or infant outcomes were identified in the treated animals, yet the placebo control treated animals also did not have signs related to congenital Zika syndrome (CZS). Human immune globulin may be a viable prophylaxis and treatment option for ZIKV infection during pregnancy, however, more studies are required to fully assess the impact of this treatment to prevent CZS.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Female
  • Humans
  • Immunoglobulins
  • Infant
  • Macaca mulatta
  • Pregnancy
  • Pregnancy Complications, Infectious*
  • Viremia
  • Zika Virus Infection*
  • Zika Virus*

Substances

  • Immunoglobulins